Comparison of the affinity of beta-blockers for two states of the beta 1-adrenoceptor in ferret ventricular myocardium.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  British Journal of Pharmacology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 11815381PMCID PMC1573134
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Potentiation of the effects of isoprenaline and noradrenaline by hydrocortisone in cat heart muscle

  2004cited by this paper
• Abolition of (-)-CGP 12177-evoked cardiostimulation in double beta1/beta2-adrenoceptor knockout mice. Obligatory role of beta1-adrenoceptors for putative beta4-adrenoceptor pharmacology.

  2001cited by this paper
• The putative beta4-adrenergic receptor is a novel state of the beta1-adrenergic receptor.

  2001cited by this paper
• beta1-adrenergic receptors mediate beta3-adrenergic-independent effects of CGP 12177 in brown adipose tissue.

  2000cited by this paper
• Both beta(2)- and beta(1)-adrenergic receptors mediate hastened relaxation and phosphorylation of phospholamban and troponin I in ventricular myocardium of Fallot infants, consistent with selective coupling of beta(2)-adrenergic receptors to G(s)-protein.

  2000cited by this paper
• Aryloxypropanolamine and catecholamine ligand interactions with the beta(1)-adrenergic receptor: evidence for interaction with distinct conformations of beta(1)-adrenergic receptors.

  2000cited by this paper
• Beta4-adrenoceptors are more effective than beta1-adrenoceptors in mediating arrhythmic Ca2+ transients in mouse ventricular myocytes.

  1999cited by this paper
• Blockade of putative beta4- and beta1-adrenoceptors by carvedilol in ferret myocardium.

  1999cited by this paper
• Desensitization and resensitization of β1‐ and putative β4‐adrenoceptor mediated responses occur in parallel in a rat model of cardiac failure

  1999cited by this paper
• Putative β4‐adrenoceptors in rat ventricle mediate increases in contractile force and cell Ca2+: comparison with atrial receptors and relationship to (−)‐[3H]‐CGP 12177 binding

  1999cited by this paper
• Cardiovascular and Metabolic Alterations in Mice Lacking Both β1- and β2-Adrenergic Receptors*

  1999cited by this paper
• Targeted Disruption of the β2 Adrenergic Receptor Gene*

  1999cited by this paper
• Action potential shortening through the putative beta4-adrenoceptor in ferret ventricle: comparison with beta1- and beta2-adrenoceptor-mediated effects.

  1998cited by this paper
• Usefulness of pindolol in neurocardiogenic syncope.

  1998cited by this paper
• Validity of (−)‐[3H]‐CGP 12177A as a radioligand for the ‘putative β4‐adrenoceptor’ in rat atrium

  1998cited by this paper
• (-)-CGP 12177 causes cardiostimulation and binds to cardiac putative beta 4-adrenoceptors in both wild-type and beta 3-adrenoceptor knockout mice.

  1998cited by this paper
• Modulation of human cardiac function through 4 beta-adrenoceptor populations.

  1997cited by this paper
• Increased survival with beta-blockers: importance of ancillary properties.

  1997cited by this paper
• Four beta-adrenoceptor subtypes in the mammalian heart.

  1997cited by this paper
• SOME QUANTITATIVE USES OF DRUG ANTAGONISTS

  1997cited by this paper
• Differences between the third cardiac beta-adrenoceptor and the colonic beta 3-adrenoceptor in the rat.

  1996cited by this paper
• Cardiac adrenergic receptor effects of carvedilol.

  1996cited by this paper
• Anomalous behavior of CGP 12177A on beta 1-adrenergic receptors.

  1996cited by this paper
• β2-Adrenoceptor activation by zinterol causes protein phosphorylation, contractile effects and relaxant effects through a cAMP pathway in human atrium

  1996cited by this paper
• (—)‐CGP 12177‐induced increase of human atrial contraction through a putative third β‐adrenoceptor

  1996cited by this paper
• Receptor pharmacology of carvedilol in the human heart.

  1992cited by this paper
• Regional differences of beta 1- and beta 2-adrenoceptor-mediated functions in feline heart. A beta 2-adrenoceptor-mediated positive inotropic effect possibly unrelated to cyclic AMP.

  1991cited by this paper
• Piglet sinoatrial 5-HT receptors resemble human atrial 5-HT4-like receptors

  1990cited by this paper
• A comparison of the effects of adrenaline and noradrenaline on human heart: the role of beta 1- and beta 2-adrenoceptors in the stimulation of adenylate cyclase and contractile force.

  1989cited by this paper
• Is there a third heart beta-adrenoceptor?

  1989cited by this paper
• Contribution of beta 1- and beta 2-adrenoceptors of human atrium and ventricle to the effects of noradrenaline and adrenaline as assessed with (-)-atenolol.

  1988cited by this paper
• Beta 2-adrenoceptor-mediated positive inotropic effect of adrenaline in human ventricular myocardium. Quantitative discrepancies with binding and adenylate cyclase stimulation.

  1987cited by this paper
• The role of a low β1-adrenoceptor selectivity of [3H]CGP-12177 for resolving subtype-selectivity of competitive ligands

  1987cited by this paper
• The beta 1-adrenoceptor antagonist CGP 20712 A unmasks beta 2-adrenoceptors activated by (-)-adrenaline in rat sinoatrial node.

  1986cited by this paper
• Direct labelling of beta 2-adrenoceptors. Comparison of binding potency of 3H-ICI 118,551 and blocking potency of ICI 118,551.

  1985cited by this paper
• The affinity of (-)-propranolol for beta 1- and beta 2-adrenoceptors of human heart. Differential antagonism of the positive inotropic effects and adenylate cyclase stimulation by (-)-noradrenaline and (-)-adrenaline.

  1985cited by this paper
• Beta blockade during and after myocardial infarction: an overview of the randomized trials.

  1985cited by this paper
• [Cardiac beta receptors--experimental aspects].

  1983cited by this paper
• CGP-12177. A hydrophilic beta-adrenergic receptor radioligand reveals high affinity binding of agonists to intact cells.

  1983cited by this paper
• Pindolol acts as beta-adrenoceptor agonist in orthostatic hypotension: therapeutic implications.

  1981cited by this paper
• Structure-basicity and structure-affinity relationships of beta-adrenergic blocking agents.

  1975cited by this paper
• Convenient apparatus for recording contractions of isolated heart muscle.

  1965cited by this paper

• Predicting compounds that interact with the 2 known agonist-induced conformations of the human β1-adrenoceptor

  2025cites this paper
• Adrenoceptors: Receptors, Ligands and Their Clinical Uses, Molecular Pharmacology and Assays.

  2024cites this paper
• Beta-blockers in cardiac arrhythmias–Clinical pharmacologist’s point of view

  2023cites this paper
• Beta-blocker treatment of patients with atrial fibrillation attenuates spontaneous calcium release-induced electrical activity.

  2022cites this paper
• Design, synthesis and cardiovascular evaluation of some aminoisopropanoloxy derivatives of xanthone.

  2018cites this paper
• Bisoprolol protects myocardium cells against ischemia/reperfusion injury by attenuating unfolded protein response in rats

  2017cites this paper
• Use of a new proximity assay (NanoBRET) to investigate the ligand‐binding characteristics of three fluorescent ligands to the human β 1‐adrenoceptor expressed in HEK‐293 cells

  2016cites this paper
• Negative cooperativity across β1-adrenoceptor homodimers provides insights into the nature of the secondary low-affinity CGP 12177 β1-adrenoceptor binding conformation

  2015cites this paper
• Detection of the secondary, low-affinity β1-adrenoceptor site in living cells using the fluorescent CGP 12177 derivative BODIPY-TMR-CGP

  2014cites this paper
• Supramolecular chiro-biomedical aspect of β-blockers in drug development.

  2014cites this paper
• MH-3: evidence for non-competitive antagonism towards the low-affinity site of β1-adrenoceptors

  2014cites this paper
• Identification of Key Residues in Transmembrane 4 Responsible for the Secondary, Low-Affinity Conformation of the Human β1-Adrenoceptor

  2014cites this paper
• DETERMINATION OF STEREO-SELECTIVE BINDINGS OF RACEMIC PROPRANOLOL WITH β2-AD-GPCR IN HUMAN PLASMA

  2012cites this paper
• The pharmacological effects of the thermostabilising (m23) mutations and intra and extracellular (β36) deletions essential for crystallisation of the turkey β-adrenoceptor

  2011cites this paper
• A Full Pharmacological Analysis of the Three Turkey β-Adrenoceptors and Comparison with the Human β-Adrenoceptors

  2010cites this paper
• Structure and function of V1b vasopressin receptor

  2010cites this paper
• Phosphodiesterases PDE3 and PDE4 jointly control the inotropic effects but not chronotropic effects of (−)-CGP12177 despite PDE4-evoked sinoatrial bradycardia in rat atrium

  2009cites this paper
• Effects of beta-adrenergic receptor blockers on cardiac function: a comparative study in male versus female rats.

  2009cites this paper
• Four close bupranolol analogues are antagonists at the low-affinity state of beta1-adrenoceptors.

  2009cites this paper
• The low-affinity site of the beta1-adrenoceptor and its relevance to cardiovascular pharmacology.

  2008cites this paper
• Carteolol, a non-conventional partial agonist of beta(1)-adrenoceptors, relaxes phenylephrine-constricted rat aorta through antagonism at alpha(1)-adrenoceptors.

  2008cites this paper
• Therapeutic implications of beta-adrenergic receptor pharmacodynamic properties.

  2008cites this paper
• Antagonist affinity measurements at the Gi-coupled human histamine H3 receptor expressed in CHO cells

  2008cites this paper
• CGP12177-induced haemodynamic and vascular effects in normotensive and hypertensive rats.

  2008cites this paper
• Atenolol Is Inferior to Metoprolol in Improving Left Ventricular Function and Preventing Ventricular Remodeling in Dogs with Heart Failure

  2008cites this paper
• In vitro cytotoxicity of eight beta-blockers in human corneal epithelial and retinal pigment epithelial cell lines: comparison with epidermal keratinocytes and dermal fibroblasts.

  2008cites this paper
• A study of antagonist affinities for the human histamine H2 receptor

  2008cites this paper
• Comparison of the binding affinity of CGP-12177A at recombinant rat alpha(1D)-adrenoceptors expressed in BHK-21 cell membranes and alpha(1)-adrenoceptors present in rat cerebral cortex membranes.

  2008cites this paper
• Multiple GPCR conformations and signalling pathways: implications for antagonist affinity estimates

  2007cites this paper
• A Comparison of the Antagonist Affinities for the Gi- and Gs-Coupled States of the Human Adenosine A1-Receptor

  2007cites this paper
• HUMAN HEART β‐ADRENOCEPTORS: β1‐ADRENOCEPTOR DIVERSIFICATION THROUGH ‘AFFINITY STATES’ AND POLYMORPHISM

  2007cites this paper
• Phosphodiesterase PDE3 blunts the positive inotropic and cyclic AMP enhancing effects of CGP12177 but not of noradrenaline in rat ventricle

  2006cites this paper
• Stress and cardiac beta adrenoceptors

  2006cites this paper
• In Vitro Evidence That Carteolol Is a Nonconventional Partial Agonist of Guinea Pig Cardiac β1-Adrenoceptors: A Comparison with Xamoterol

  2005cites this paper
• Site of Action of β-Ligands at the Human β1-Adrenoceptor

  2005cites this paper
• Positive inotropic and lusitropic effects mediated via the low‐affinity state of β1‐adrenoceptors in pithed rats

  2005cites this paper
• Evidence for a secondary state of the human beta3-adrenoceptor.

  2005cites this paper
• Aspartate138 is required for the high-affinity ligand binding site but not for the low-affinity binding site of the β1-adrenoceptor

  2004cites this paper
• Characterization of intrinsic sympathomimetic activity of carteolol in rat cardiovascular preparations.

  2004cites this paper
• Overexpression of β1‐adrenoceptors in adult rat ventricular myocytes enhances CGP 12177A cardiostimulation: implications for ‘putative’β4‐adrenoceptor pharmacology

  2004cites this paper
• Role of alpha-adrenergic receptors in the effect of the beta-adrenergic receptor ligands, CGP 12177, bupranolol, and SR 59230A, on the contraction of rat intrapulmonary artery.

  2004cites this paper
• Role of α-Adrenergic Receptors in the Effect of the β-Adrenergic Receptor Ligands, CGP 12177, Bupranolol, and SR 59230A, on the Contraction of Rat Intrapulmonary Artery

  2004cites this paper
• Markedly reduced effects of (-)-isoprenaline but not of (-)-CGP12177 and unchanged affinity of beta-blockers at Gly389-beta1-adrenoceptors compared to Arg389-beta1-adrenoceptors.

  2004cites this paper
• Binding of (-)-[3H]-CGP12177 at two sites in recombinant human beta 1-adrenoceptors and interaction with beta-blockers.

  2004cites this paper
• Localization of Pacemaker Channels in Lipid Rafts Regulates Channel Kinetics

  2004cites this paper
• Agonist actions of "beta-blockers" provide evidence for two agonist activation sites or conformations of the human beta1-adrenoceptor.

  2003cites this paper
• Atypical cardiostimulant β‐adrenoceptor in the rat heart: stereoselective antagonism by bupranolol but lack of effect by some bupranolol analogues

  2003cites this paper
• Pharmacology and direct visualisation of BODIPY‐TMR‐CGP: a long‐acting fluorescent β2‐adrenoceptor agonist

  2003cites this paper
• Physiological antagonism between ventricular beta 1-adrenoceptors and alpha 1-adrenoceptors but no evidence for beta 2- and beta 3-adrenoceptor function in murine heart.

  2002cites this paper
• Mg2+ efflux from the isolated perfused rabbit heart is mediated by two states of the β1-adrenergic receptor

  2002cites this paper
• Pharmacological characterization of CGP 12177 at the human beta(2)-adrenoceptor.

  2002cites this paper
• (-)-CGP 12177 increases contractile force and hastens relaxation of human myocardial preparations through a propranolol-resistant state of the β1-adrenoceptor

  2002cites this paper